Skip to Content

Olink Holding AB ADR OLK

Morningstar Rating
$23.02 +0.34 (1.50%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

OLK is trading at a 7% premium.
Price
$22.74
Fair Value
$66.68
Uncertainty
Very High
1-Star Price
$19.71
5-Star Price
$77.39
Economic Moat
Ndd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OLK is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$22.68
Day Range
$22.6623.04
52-Week Range
$14.1326.01
Bid/Ask
$23.02 / $23.07
Market Cap
$2.86 Bil
Volume/Avg
16,578 / 553,167

Key Statistics

Price/Earnings (Normalized)
Price/Sales
16.58
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Olink Holding AB has a proprietary and patented Proximity Extension Assay technology, which enables researchers to use one platform for discovery to clinical trials to diagnostic applications utilizing the established infrastructure of labs and installed instrumentation. It has two segments including Kit and Services. It derives revenues from Sweden, the United States which also generates key revenue, China, EMEA (Excluding Sweden) Japan, and other regions.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Total Number of Employees
707

Valuation

Metric
OLK
Price/Earnings (Normalized)
Price/Book Value
5.61
Price/Sales
16.58
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
OLK
Quick Ratio
3.55
Current Ratio
4.75
Interest Coverage
−53.10
Quick Ratio
OLK

Profitability

Metric
OLK
Return on Assets (Normalized)
−4.17%
Return on Equity (Normalized)
−4.83%
Return on Invested Capital (Normalized)
−5.59%
Return on Assets
OLK
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncGnyqscyjnBlr$219.5 Bil
DHR
Danaher CorpPwwsxpkwdXvgkh$182.9 Bil
IQV
IQVIA Holdings IncPpmsbfdsmFhwlm$42.4 Bil
A
Agilent Technologies IncZxqtshrhKnjh$40.6 Bil
IDXX
IDEXX Laboratories IncSnqzlvkkqzZsptvjd$38.7 Bil
MTD
Mettler-Toledo International IncVmhmzcvvPrnszh$26.7 Bil
ICLR
Icon PLCKzgkgjkDghpy$24.9 Bil
ILMN
Illumina IncVxhdhlscHnlntm$19.9 Bil
WAT
Waters CorpPtmcdhkdRtyx$18.7 Bil
LH
Laboratory Corp of America HoldingsYbkmjdyzyQbnxkbw$17.0 Bil

Sponsor Center